The variability and delay in utilizing evidence in clinical practice are barriers to improving care, quality, and cost in health care, as charged by the "triple aim" framework. Scientific research provides an avenue not only to further the field of pain research, but also to study and change the patterns and processes that drive systemic and individual clinical practices. Implementation science is an emerging field that can be integrated with more traditional effectiveness research to accomplish a combination of aims within the same study. This type of concurrent study of effectiveness and implementation is known as a hybrid design and can be used to improve behavioral or operational practice patterns as well as to collect evidence of clinical effectiveness. Recently, the National Pain Strategy put forth recommendations to improve the care of patients with pain through research and practice. Hybrid designs align well with recent efforts that emphasize value-based, patient-centered health care evolving and described in the National Pain Strategy. The purposes of this perspective are to describe implementation science and hybrid studies and to put forth opportunities to utilize this research to advance the care of patients with pain in the United States.
The variability and delay in utilizing evidence in clinical practice are barriers to improving care, quality, and cost in health care, as charged by the "triple aim" framework. Scientific research provides an avenue not only to further the field of pain research, but also to study and change the patterns and processes that drive systemic and individual clinical practices. Implementation science is an emerging field that can be integrated with more traditional effectiveness research to accomplish a combination of aims within the same study. This type of concurrent study of effectiveness and implementation is known as a hybrid design and can be used to improve behavioral or operational practice patterns as well as to collect evidence of clinical effectiveness. Recently, the National Pain Strategy put forth recommendations to improve the care of patients with pain through research and practice. Hybrid designs align well with recent efforts that emphasize value-based, patient-centered health care evolving and described in the National Pain Strategy. The purposes of this perspective are to describe implementation science and hybrid studies and to put forth opportunities to utilize this research to advance the care of patients with pain in the United States. D espite literature suggesting that adherence to evidence-based clinical practice guidelines improve patient outcomes and decrease health care utilization and costs, 1 there remains a disconnect between clinical evidence translation and clinical practice. [2] [3] [4] The wide variability in clinical practice patterns that exists is not the fault of any one provider, researcher, administrator, payer, academic, or policy maker. [5] [6] [7] [8] This science-to-service lag is a complex emergent issue that is not exclusive to the physical therapy profession. 9 ,10 Recognition of the consequences of this gap has led to the development of a new branch of research called implementation science. [11] [12] [13] Defined as "the study of methods to promote the systematic uptake of research findings and other evidence-based practices into routine practices," 14 implementation research is also known as knowledge translation research because the goal of this type of research is to find ways to improve the translation of existing knowledge (evidence) into routine clinical practice. More recently, there has been a growth in the development of different varieties of implementation research study designs, along with a growth in the number of supporting funding opportunities. 15, 16 This may be a result of increased political and societal pressure to improve the cost, utilization, and delivery of health care in the United States (US), as put forth in the "triple aim" framework.
The triple aim framework 17 charges the US health care system to focus on 3 specific aims: improving individual patient care, improving the health of populations, and reducing the per capita cost of health care. In 2011, the Institute of Medicine (now the National Academy of Medicine) investigative report on pain in America 18 prompted multiple organizations, including the American College of Physicians 19 and the US Department of Health and Human Services, 20 to publish similar reports espousing procedural and behavioral changes in the approach to preventing, managing, and treating pain. Shortly thereafter, Lentz et al 21 described a value model for the prevention and management of chronic musculoskeletal pain that integrates the triple aim in a stepwise system useful for guiding health care development at 4 levels: the patient, provider, organization, and system. Implementation science could provide an avenue to reinforce triple aim efforts by promoting health care practice improvements that address care, quality, or cost at each of these levels. Once a process, intervention, or behavioral change has demonstrated improvements in clinical outcomes (care), patient satisfaction (quality), or expenditure (cost), it should then be strategically and broadly implemented at the appropriate level of care. By developing systematic and measured implementation approaches, behavioral, operational, or policy changes can be applied to positively affect the patient, provider, organization or system. 22 These systematic approaches are the essence of implementation research and are used to study change in practice, which is different from foundational "bench side" research methods and clinical trials.
Implementation Research Versus Clinical Research
Implementation science, or knowledge translation research, is fundamentally different from traditional clinical research because it focuses on the behavior of health care professionals and other stakeholders as a key variable and seeks to overcome barriers and optimize facilitators associated with the uptake of existing evidence into everyday clinical practice. 22 Clinical research trials, on the other hand, produce evidence about the effectiveness or efficacy of different treatments under confines of strict measures to maximize internal validity and establish treatment effect sizes. Outcomes of these trials are purported to help guide clinical decision making when faced with a patient case. The assumption is that once effectiveness of an intervention has been established, the standard of care will shift to reflect current evidence. This assumption largely relies on passive dissemination of the new evidence, with the expectation that providers or organizations will adopt and implement the evidence. However, relying on this passive dissemination approach has been shown to be ineffective for creating change. 23, 24 Implementation trials, on the other hand, attempt to systematically study and create change with a focus on evaluating the implementation barriers, processes, or strategies. 11, 25 Rather than guiding which intervention to use (ie, the purpose of efficacy or effectiveness trials), the outcomes of implementation trials guide the process for adopting and sustaining an evidence-informed intervention. The focus of analysis is on the provider, process, or organization-not necessarily on the patient or the clinical outcome. Importantly, this difference of focus does not imply any type of hierarchy in research. Implementation trials do not take the place of clinical trials, but rather follow them in the linear progression of science-toservice ( Fig. 1) and, if successful, can create long-term sustainable change in practice. The ultimate outcome is the translation of evidence into practice, and the knowledge of how to replicate the implementation strategy in other settings.
Given the pressures to improve quality of care and clinical outcomes for patients in pain, rehabilitation clinicians and researchers should consider developing and participating in implementation research to increase the adoption of evidence-based practices in various health care settings. To do so, the rehabilitation field must understand the general concepts of implementation research, how it can be conducted, and what its value may be. In this perspective, we describe the importance and utility of implementation science by first presenting the differences and similarities between quality improvement initiatives and implementation research. Next, we introduce and exemplify a new type of research design, known as hybrid trials, as a practical and novel opportunity to expedite the translation of science to service. Last, we propose that the National Pain Strategy (NPS) is a motivator for conducting implementation research in the field of pain. This perspective contends that implementation science will be paramount in a national effort to improve care, quality of care, and cost of treating patients in pain.
Implementation Trials and Quality Improvement Quality Improvement
Quality improvement (QI) and implementation science share similar traits that encourage improved processes and outcomes, yet they have some important differences. Fundamental commonalities and contrasts between QI projects and implementation research studies are shown in Figure 2 . QI initiatives are defined as data-guided activities designed to bring about immediate improvements in health care delivery in a particular setting. 26 QI projects arise from individual providers, clinics, or systems in need of addressing a specific challenge or problem. These problems may be clinically focused but could also be operationally or administratively motivated (eg, decreasing patient cancellation rates). An important distinction of QI initiatives is that the strategies aimed at improving care are developed specific to a problem or a challenge within that system and then deployed within that same system. 22, 27 For example, nurse leaders at Kaiser Permanente (KP) Northern California (KPNC), a large integrated health care system, identified that KPNC had lower scores of patient satisfaction with pain management compared with the national average. Recognizing an opportunity for improvement, they developed a QI project to address the weaknesses. 28 In this setting, in-depth exploration of nurses' experiences with pain management was required, followed by analysis of information and development of a solution. This extensive process led to implementation of a pain-based best-practice initiative, called KP Painscape, to change various clinical and administrative practices for pain management. Over the course of 5 years of this QI initiative, KPNC patient satisfaction scores improved from the 25th percentile to the 75th percentile.
This initiative is an example of a successful QI project that was tailored to the specific needs, setting, and clinical discipline in which it was conducted. The QI strategies that proved successful within the parameters of the KPNC setting, however, might not generalize to other health care settings. Operations of an integrated system can differ significantly from nonintegrated networks, and the experiences of the nurses in other health care settings could be unlike those at KPNC. If the nurse leaders wanted to design an implementation study instead of a QI initiative, they would have had to systematically define and study the implementation strategies they used in order to allow the project to be replicated outside of their setting.
Implementation strategies are often designed from theoretical or empirical frameworks with the intention of reproducing the results in systems outside of the study. 29 To increase generalizability, researchers will first identify the barriers to a behavioral change and then develop strategies using behavior change techniques that are mapped to overcoming each specific barrier. This process is known as intervention mapping. 30 Researchers seek to identify and differentiate between the critical core components of an implementation strategy and the adaptable components of that strategy. By identifying those components that are adaptable versus those that are critical to driving behavioral change, other systems or providers can attempt to adapt these strategies to their own distinct setting. This evaluation of strategic processes requires methodological rigor and is a characteristic that distinguishes implementation trials from QI projects.
Implementation Trials
The systematic development and study of strategic processes are a fundamental component of implementation trials and encourage the active translation of evidence into practice. Referring back to the project at KP, 28 a QI question might have been: "Can we develop a program that increases our patient satisfaction scores?" whereas an implementation question might have been: "Is 'strategy x' more effective, less costly, or more sustainable than 'strategy y' for implementing KP Painscape to increase patient satisfaction scores?" The former of these 2 questions illustrates the ability of an individual system to change, whereas the latter describes the best methods to accomplish that change. It is pertinent to point out that in developing the hypothetical implementation question, there was an underlying presumption that KP Painscape had already demonstrated effectiveness for improved quality-of-care outcome, which is not the motivation for implementation research. Instead, implementation trials are focused on studying the barriers, processes, and strategies to implementing effective interventions in real-world clinical practice. In the translation of evidence to practice, implementation trials occur as the last step to actively identify methods to ensure that the benefits of research are realized. Increased awareness of implementation research has led to the defining and testing of different strategic implementation methods that can be reproduced and studied. Proctor et al 31 provide detailed guidelines for naming, defining, and specifying the implementation strategy to ensure consistency among implementation trials and encourage reproducibility. Powell et al 32 published a compilation of the implementation strategies commonly used in implementation research studies. 32 To further standardize the methodology for describing and reporting implementation trials, Pinnock et al 33 developed the Standards for Reporting Implementation statement and checklist. This scientific approach to conducting and reporting implementation studies promotes the generation and propagation of evidence and helps differentiate implementation research from quality improvement projects.
As an example, Riis et al 34 evaluated the effectiveness of a multifaceted, active implementation strategy versus a passive diffusion strategy for improving the use of low back pain guidelines in Denmark. They compared passive diffusion of guidelines through continuing education conferences and a newsletter with an active, multifaceted approach using external facilitation and audit and feedback. External and internal facilitation are common implementation strategies that use content experts to educate, support, and motivate staff to adopt a new practice pattern or behavior. 35 Facilitation is internal or external depending on whether the experts are within (internal) or outside of (external) the organization. Audit and feedback are the process of setting a performance goal and giving feedback of performance data to clinicians to inform progress toward their target. 36, 37 The outcomes analyzed were cost effectiveness, referral rates, and patient-reported satisfaction and function. The active, multifaceted approach did indeed change referral patterns and decrease costs; however, patients reported less satisfaction with their care. These are the opportunities and challenges of conducting implementation trials in the context of the triple aim framework; the approach expedited the translation of evidence into practice (care) and decreased health care expenditure (costs)-but it occurred at the expense of patient satisfaction (quality).
A study by Suman et al 38 further illustrates the systematic approaches used in implementation trials while reiterating the barriers within this type of research design. As part of a broader cost-effectiveness trial, 39 they evaluated strategies to increase the use of an eHealth campaign that promoted low back pain guidelines. 40 They identified facilitators and barriers to the implementation of their eHealth campaign, tracked the use of the eHealth portal, and collected feedback on the satisfaction and feasibility of the campaign. The underwhelming adoption of the eHealth portal demonstrates both the need for implementation research and the challenges to it. There might be evidence supporting the clinical effectiveness of an intervention for a condition (eg, low Venn diagram depicting the differences and overlap of the components of quality improvement projects and implementation research. QI = quality improvement.
back pain guidelines); however, when there is political and societal pressure to improve management for that condition, and when there is a systematic process to implement the intervention, there can still be internal and external barriers to behavioral change that will affect the effectiveness of the intervention. 41, 42 As an example of internal barriers, the cultural norms and values of an organization or system might be averse to the intervention and preclude implementation efforts. 43 There could also be systemic resistance to change due to hierarchical rigidity, lack of proficiency or competency, or perceived uselessness. 22 External barriers may include societal and/or political motivations that impede new practice patterns or behaviors, 41 such as insurance policies or reimbursement that restricts the freedom needed by an organization to make changes. Moreover, as seen in the study by Riis et al, 34 patients of the organization may not desire new interventions or changes in practice.
Any of these internal or external barriers can create challenges for implementation efforts and potentially dampen or negate the effect of a clinical intervention. It is not safe to assume that interventions proven beneficial in controlled trials will maintain their effectiveness in various real-world settings. This is why it is also important to measure the clinical success of an intervention when studying an implementation process. Measuring this outcome (essentially an effectiveness outcome), ensures that the intervention remains clinically beneficial when implemented in a different setting. Assessing implementation and effectiveness outcomes efficiently and simultaneously requires a different type of study design: a hybrid approach.
Hybrid Designs: Combining Clinical Effectiveness and Implementation Research
Among the new types of translational research designs is an interesting combination of 2 pragmatic research approaches into a hybrid approach. Known as effectiveness-implementation research, Curran et al 44 describes this approach as "a study design that takes a dual focus in assessing clinical effectiveness and implementation." This unique approach is an attempt to produce evidence that guides not only patient care (clinical effectiveness) but also strategies to facilitate the uptake of evidence-based interventions (implementation). By incorporating an implementation aim into an effectiveness trial, researchers and clinicians are forced to describe, execute, study, and report a systematic plan to move their intervention into practice. Meanwhile, data on the effectiveness of the intervention are also collected. Therefore, if successful, this type of trial produces evidence for the effectiveness of an intervention and for the process of implementing the intervention. This is a novel conceptual change from the traditional linear and stepwise dissemination approach of conducting a clinical trial, then conducting a separate implementation trial to guide the adoption of the clinical evidence into practice. By combining the 2 steps of this progression into a single hybrid study, the translation of evidence into practice can theoretically occur more rapidly (Fig. 3) .
The outcomes in these hybrid studies include standard clinical measures of patient improvement (ie, effectiveness) as well as broader provider, organizational, or system-level measures such as rates of intervention adoption, feasibility, fidelity, and sustainability of the intervention in clinical practice settings (ie, implementation). 44 The concurrent collection of clinical and implementation data provides researchers the capability to answer 2 distinct and necessary questions for changing clinical practice:
• Is this intervention helpful for this broad group of patients in a pragmatic "real-world" environment (effectiveness)?
• How can this intervention be adopted at an individual and/or systemic level (implementation)?
Additionally, as done in implementation trials, the actual process of the study can build clinical infrastructure and behavioral changes that can be maintained after the trial ends and that can be generalized to other providers and health care systems.
It is pertinent to remember that the barriers and limitations previously described in implementation trials are also relevant to these hybrid research designs. Effectiveness studies have limitations as well, often sacrificing internal validity (ie, forgoing strict protocols and rigid inclusion/exclusion criteria) in exchange for pragmatism and generalizability. Additionally, from a relative perspective, hybrid designs are new, innovative, and underrepresented in research and, therefore, could be considered a developing study design that has yet to be fully validated.
Bearing in mind these challenges, the different types of hybrids offer unique opportunities to implement change, capture data, and improve care. Curran et al 44 categorize hybrid effectiveness-implementation research designs into 3 types depending on the emphasis of the aims (Table) . The following sections pull studies from outside of the pain literature to describe and exemplify each design, and then conclude with opportunities and challenges for future translational efforts in pain research.
Type 1 Hybrid Design
Beidas et al 45 conducted a type 1 hybrid trial in their study of group exercise Expediting the progression of evidence into practice using hybrid studies.
programs for survivors of breast cancer. Initial explanatory trials had demonstrated the efficacy of an exercise program for physical function and quality of life in survivors. 46 Instead of sequentially testing effectiveness and then implementation in 2 separate studies, they designed a type 1 hybrid study to observe 2 separate aims concurrently. The primary effectiveness aim studied the benefit of the group exercise program in a community-based physical therapy setting and found it beneficial for strength, lymphedema symptoms, and body image. The secondary implementation aim qualitatively assessed internal and external barriers from the perspectives of the referring oncology clinicians and the physical therapists. For example, an external barrier was the expense of the class to the participants and the variability of insurance coverage. Internal barriers were the lengthy processes and time restraints that oncology physicians expressed had impacted their ability to identify and refer appropriate patients into the program.
Outcomes of this study elucidate the clinical and operational utility of the hybrid design. Clinically, the effectiveness aim of this study informs practitioners and administrators that a group exercise class, in a real-world setting, is indeed helpful for survivors of breast cancer. 45 Operationally, in order to implement this program, support and infrastructure are needed at different levels of the delivery system-in this case, financial support by third-party payers and an efficient and valid referral process for oncology clinicians. Notably, when compared with the preceding efficacy study, there were slightly fewer clinical improvements in muscle strength. Because this was an effectiveness aim, different parameters were applied to increase the intervention's pragmatism. 
Type 2 Hybrid Design
In a type 2 hybrid design, the effectiveness and implementation aims are given equal importance and are both considered to be primary aims. Importantly, this design assumes that the clinical and implementation interventions have considerable foundational or indirect evidence, pose minimal risk, and would benefit from an investigation of their applicability in another setting or population. 44 These coprimary aims challenge the research team to conduct a study that will rigorously evaluate both clinical and implementation effectiveness. This is not as simple as adding on an implementation aim to the list of primary clinical aims in the study design. Adding a primary implementation aim will require a different unit of analysis (eg, providers, clinics), outcomes, and methodology. Input will be needed from investigators with a different set of skills and expertise, which often necessitates expanded research teams that add to the complexity and costs of the study.
Cully et al 47 designed a type 2 hybrid study of the effects of brief cognitive-behavioral therapy (bCBT) on patients with anxiety and depression. Their effectiveness aim was to determine whether a bCBT treatment group was superior to an enhanced usual care control group as measured by anxiety, depression, and quality of life outcomes. For the implementation aim, they assessed the feasibility for and the acceptability and adoption of bCBT by primary care physicians, after delivering a multilayered implementation strategy that included online modules, fidelity auditing, and internal and external facilitation. Both interventions-the multilayered implementation strategy and bCBT-have independent evidence of effectiveness. 32, 48 Combining the 2 offers an opportunity to evaluate implementation strategies that may maximize the clinical effectiveness of bCBT.
Outcomes of this type 2 hybrid study showed promising evidence that (1) this multifaceted approach to implementing an evidence-based intervention can induce change in the clinician's knowledge and practice 49, 50 and (2) delivering bCBT was well received by the patients. 50 The effectiveness outcomes also showed modest improvements in depression, anxiety, and short-term quality of life. 50 The authors proposed that "[Hybrid designs] have the potential to rapidly advance the knowledge of both the clinical effectiveness of bCBT and the possible implementation of best practices necessary to support the use of this complex intervention in real-world care." 47 Knowing they have a strong implementation intervention for a beneficial clinical intervention, the researchers are poised to broadly apply or scale their approach to various settings, environments or populations and evaluate the generalizability of their implementation. Emphasizing implementation over effectiveness is the essence of a type 3 hybrid.
Type 3 Hybrid Design
In this type of hybrid study, the design is focused primarily on implementation, with a secondary clinical effectiveness aim, essentially the opposite of a type 1 study. Type 3 trials can be especially useful when there is societal, political, or organizational pressure to urgently implement changes in practice patterns or behaviors and when there is sufficient evidence for an implementation intervention. As mentioned in the introduction, there is massive political and social motivation in the United States to implement effective nonopioid interventions for the treatment of pain. These implementation efforts should be studied in order to make generalizable recommendations that maximize effective change. Type 3 hybrids emphasize the evaluation of implementation approaches, while secondarily collecting information about the effectiveness of the treatment. This treatment should have strong evidence as an effective, safer, and/or less expensive intervention.
For example, the Affordable Care Act requires all Medicare enrollees to undergo a comprehensive health risk assessment and a thorough family history. 51 Realizing the urgency and importance of this task, Wu et al 52 designed an ongoing type 3 hybrid to evaluate the implementation of a web-based risk assessment tool in primary care clinics and to study the effectiveness of its implementation. The primary implementation outcome is the enrollment rate of providers, clinics, and patients in the web-based system and how well those who enroll represent the general population. The effectiveness outcomes are the percent of patients appropriately screened and the percent of those identified as having an increased risk. The methodology of this type 3 trial illustrates fundamental implementation components. They are using an established systematic model to assess their intervention's potential to broadly improve population health and the likelihood that the intervention will be translated into clinical practice.
To facilitate generalizability, the researchers specifically chose 5 distinct medical centers that represent different geographical and operational systems with an educationally, ethnically, and economically diverse population. The ultimate outcomes of this trial would advise a feasible, sustainable, adaptable process for implementing an effective electronic risk assessment tool. If the assessment tool is indeed helpful, the infrastructure to maintain it exists in these 5 sites, therefore facilitating the translation of the science (risk screening) to service (patient care).
The dynamic utility of hybrid designs makes them an appealing opportunity for studying and enacting necessary changes in health care. The public health issues that motivated the Wu trial are very similar to the current national efforts and initiatives to improve the medical management of pain.
Future Direction for Implementing a National Pain Strategy
Spurred by social and political pressure, the National Pain Strategy 20 is a comprehensive population-level health strategy developed through a partnership between the Institute of Medicine (now the National Academy of Medicine) and the National Institutes of Health, in response to an Institute of Medicine report in 2011 urging a cultural transformation of pain prevention, care, education, and research. Embedded in many of the NPS objectives are suggestions to develop and implement various clinical, political, societal, and academic plans to decrease the burden and improve the care of pain in the health care system. The NPS advocates research efforts to study the prevention of pain and the adoption of biopsychosocial approaches to pain. The NPS promotes real-world research that can be translated and disseminated effectively and, therefore, it supports study designs that emphasize pragmatism and generalizability. The NPS provides a rationale and a strong foundation for conducting hybrid effectiveness-implementation trials not only to evaluate the effectiveness of treatments but to evaluate implementation strategies that can facilitate rapid practice improvement.
One of the primary objectives of the NPS is to decrease the utilization of ineffective and costly interventions in lieu of patient-centered biopsychosocial care. 20 These objectives motivate physical therapy research in clinical effectiveness and implementation. Despite years of practice guidelines recommending against the use of passive modalities such as ultrasound for chronic musculoskeletal problems, 53,54 these ineffective treatments are still being used in everyday practice. 3, 55, 56 Similarly, interventions with known effectiveness, such as thrust manipulation, 19 are still not universally incorporated. 57 Discrepancies between science and service such as these are ripe for effectivenessimplementation research. However, we must advance our knowledge to understand the factors necessary to implement, sustain, and scale the interventions that are evidence-based, interdisciplinary, multimodal, and grounded in current pain knowledge.
Greater emphasis needs to be placed on identifying how and where to implement effective clinical practices, such as educating patients about pain, 58, 59 using psychosocial assessments and stratifying care based on psychosocial comorbidities, 60, 61 and utilizing psychologically informed interventions such as graded exposure. 62 This is where effectiveness-implementation studies can make an impact and accelerate changes in practice. A type 1 study could identify the internal and external barriers preventing the uptake of any of these interventions, while also searching for facilitators that would promote change. A type 2 study could devise empirically or theoretically informed strategies to be tested for feasibility, sustainability, and/or cost. A type 3 study could inform which implementation strategies are most effective in creating behavioral change. In each of these hypothetical studies, concurrent clinical outcomes could be collected to inform effectiveness of both the biopsychosocial intervention and the implementation strategy. These 2 aims facilitate data collection and operational processes that could align physical therapist practice with the National Pain Strategy.
This perspective article advocates the use of effectiveness-implementation studies as an important future direction for physical therapy research, while acknowledging the arduous undertaking that this will be. Creating and sustaining behavioral change is not an easy task. For example, Mesner et al 63 recently conducted a systematic review of implementation strategies used to increase the uptake of best practice guidelines for nonspecific low back pain. They examined the range and variety of implementation strategies and then evaluated their effectiveness. Indeed, implementation efforts can successfully change health care practitioner behaviors and be associated with improved clinical outcomes-a positive finding for implementation research. However, they also found that one-time, simple implementation strategies, while easy and inexpensive, were rarely successful. The critical components of successful strategies were the frequency and duration, not necessarily the type. Ongoing internal and external facilitation created significant changes in practice behavior and patient outcomes, whereas 1-day educational seminars were essentially ineffective. Describing the difficulty this presents, the authors state that "…it is likely that such implementation interventions might be costly and time consuming, require changes to the structure of health care practitioners' duties as well as changes to the structure, policies, and procedures of health care systems. In summary, ongoing support may be needed to effect a change in the culture of the individual health care practitioners and the organization within which they work to ensure sustained change in practice that is in line with best available evidence." 63 Clearly, there is much to be learned to maximize behavioral change in health care providers and systems. This responsibility will require research efforts supported by policy makers, payers, systems, providers, and patients. Though the challenges may be numerous and complex, we must undertake research that guides the most effective and efficient ways to bring about change in practice and outcome. We believe a necessary path to this knowledge is through implementation or hybrid trials that study methods to improve the care, quality, and cost of pain care.
Conclusion
The National Pain Strategy urges a cultural transformation of pain prevention, care, education, and research. For this transformation to occur, behavioral and procedural changes must take place. Broad, methodologically rigorous implementation efforts should be attempted to understand and transform systemic and individual practice patterns and behaviors. Augmenting large pragmatic effectiveness trials with implementation aims, and vice versa, offers an opportunity to collect valuable data that will guide this progress. The 3 types of hybrid designs have the potential to improve the care, quality, and cost of physical therapy and align clinical practice with the National Pain Strategy.
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